DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis: By Ingredient (Synthetic, Biological and Others By Type of Drug and By Applications With Forecast (2016-2021)" report to their offering.
The active ingredient of a pharmaceutical drug is called an active pharmaceutical ingredient. HPAPI are compounds used to treat diseases such as cancer, hormonal imbalances, respiratory disorders, among others. High performance active pharmaceutical ingredients (HPAPI) are the fastest growing segment of the active ingredient market. Advances in clinical pharmacology and oncology research are some of the main reasons driving the growth of the HPAPI market.
An increasing geriatric population across the globe coupled with lifestyle related diseases in the younger generation are factors that are causing an increase in cancer, diabetes, cardiovascular diseases, among others. In the case of cancer, current treatments methods such as chemotherapy have severe side effects as well as they affect the non cancerous cells. Favorable government regulations are also helping with development of the pipeline of efficient drugs which is further augmenting the HPAPI market.
Companies Mentioned:
- Bristol-Myers Squibb Company
- Novartis International AG
- Sanofi Aventis
- Pfizer Inc.
- Lonza Group
- Novasep
- Hospira Inc.
- BASF AG
- Merck & Co., Inc.
- Sigma Aldrich Corporation
- Bayer AG
- Boehringer Ingelheim GmbH
- Lonza
- Teva Pharmaceuticals Industries Ltd.
Report Structure:
1. High Performance Active Pharmaceutical Ingredients - Market Overview
2. Executive Summary
3. High Performance Active Pharmaceutical Ingredients - Market Landscape
4. High Performance Active Pharmaceutical Ingredients - Market Forces
5. High Performance Active Pharmaceutical Ingredients Market - Strategic Analysis
6. High Performance Active Pharmaceutical Ingredients Market - By Type of Ingredient
7. High Performance Active Pharmaceutical Ingredients Market - By Type of Drug
8. High Performance Active Pharmaceutical Ingredients Market - By Application
9. High Performance Active Pharmaceutical Ingredients Market - By Geography
10. High Performance Active Pharmaceutical Ingredients Market - Market Entropy
11. Company Profiles
12. Appendix
For more information about this report visit http://www.researchandmarkets.com/research/vgtzxw/high_performance
